Skip to main content
Caplight Logo









Fuse Health

Fuse Health

Private
United StatesHealthcare & Life Scienceshttps://www.fusehealth.com/

Last Round

M&A

May 21, 2025

Company Overview

Fuse Health operates in Healthcare & Life Sciences and is based in the United States. It was founded in 2026.

Fuse Health is a health technology company that provides a white-label telehealth and clinical infrastructure platform for peptide-based wellness brands.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Vertical SaaS, Compliance, Creator Economy, Pharma Supply Chain

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Fuse Health Comparables

Compare Fuse Health with similar companies based on industry and business-model similarity.

Fuse Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Karpa Health
89%
Remedora Inc.
88%
Altro Health
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Fuse Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AMay 21, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Fuse Health Investors

Notable investors and investment history

Fuse Health investors
InvestorRounds
TowerBrookM&A
SoftBank Investment AdvisersM&A
Illumina VenturesM&A
Olive Tree CapitalM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2025

    Funding round included TowerBrook and SoftBank Investment Advisers.

Book a demo to see all signals

For institutional investors. Book with your work email.

Fuse Health Filings

Explore SEC and related filing metadata, where available.

Fuse Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Fuse Health's valuation, stock price, and market status.

Is Fuse Health a public or private company?

Fuse Health is a private company.

What is the current stock price of Fuse Health?

Fuse Health is a private company, so its shares have no public market price. Caplight tracks Fuse Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Fuse Health worth (valuation)?

Valuation information for Fuse Health is not publicly available.

Can I buy Fuse Health stock?

Fuse Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Fuse Health's last funding round?

Fuse Health's most recent funding round was M&A on May 21, 2025.

Who are the main investors in Fuse Health?

Key investors in Fuse Health include TowerBrook, SoftBank Investment Advisers, Illumina Ventures, Olive Tree Capital.

Will Fuse Health IPO soon?

No public IPO plans have been announced for Fuse Health.

How can I track Fuse Health secondary market activity?

Caplight tracks bids, offers, and trades in Fuse Health's shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Year Founded2026
Last FundingMay 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?